Cellular Biomedicine Group Inc (CBMG) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CBMG Annual Balance Sheets →
Tracking balance sheet results across Cellular Biomedicine Group Inc to Sep 30 2019 helps illustrate how Sep 30 2020's financial position has responded to changing business conditions.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2020)
(Jun 30 2020) (Mar 31 2020) (Dec 31 2019) (Sep 30 2019)
Assets
Cash & cash equivalent26.03
Restricted Cash and Cash Equivalents, Current0.00
Cash & Short-term Investments26.00
Accounts receivable0.03
Other Receivables0.30
Other Current Assets0.00
Prepaid Expense, Current AS1.51
Total Current Assets27.87
Equipment/Property/Plant Net24.69
Goodwill net7.68
Long-term investments0.00
Prepaid Expense and Other Assets, Total7.88
Other Assets, Noncurrent10.00
Finance Lease Right Of Use Asset18.52
Total Assets93.09
Liabilities
Accounts Payable, Current AC2.75
Accrued Liabilities, Current AC1.73
Short-term Debt DE147.87
Other Liabilities, Current6.92
Taxes Payable, Current, Total0.03
Total Current Liabilities59.30
Total Long-term Debt0.00
Other liabilities, Noncurrent16.47
Total Liabilities75.76
Stockholders' Equity
Common Stock Value0.02
Treasury Stock Value-14.99
Additional Paid In Capital Common Stock275.34
Retained Earnings / Accumulated Deficit-242.08
Other Equity-0.96
Common Stockholder's Equity17.32
Total Stockholder's Equity17.32
Liabilities & Stockholder's Equity93.09
4 historic quarters locked

Sign in to unlock the full Cellular Biomedicine Group Inc balance sheet history.

About CBMG Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.